Synapse - Prasad Adusumilli

Search Within

Prasad S Adusumilli

Results (77)

Unexpected histologic and molecular features in tumors of long-term survivors (LTS) of diffuse pleural mesothelioma (DPM)

Meeting Abstract

Baine, M.; Adusumilli, P.; Bodd, F.; Ladanyi, M.; Offin, M.; Travis, W.; Yang, S. R.; Ventura, K.; Zauderer, M.; Sauter, J.
Laboratory Investigation (2022)

Fulltext@MSK | Save

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Journal Article

Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
Nature Biotechnology (2022)

Fulltext@MSK | Save

Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor

Meeting Abstract

Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab

Journal Article

Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
Cancer Discovery (2021)

Fulltext@MSK | Save

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: A retrospective study

Journal Article

Zauderer, M. G.; Martin, A.; Egger, J.; Rizvi, H.; Offin, M.; Rimner, A.; Adusumilli, P. S.; Rusch, V. W.; Kris, M. G.; Sauter, J. L.; more...
The Lancet Digital Health (2021)

Fulltext@MSK | Save

Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing

Journal Article

Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
Molecular Therapy - Methods & Clinical Development (2021)

Fulltext@MSK | Save

Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes

Journal Article

Chang, J. C.; Offin, M.; Falcon, C.; Brown, D.; Houck-Loomis, B. R.; Meng, F.; Rudneva, V. A.; Won, H. H.; Amir, S.; Montecalvo, J.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma

Journal Article

Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Utility of dual YAP/TAZ-NF2 immunohistochemistry in the diagnosis of malignant pleural mesothelioma and in predicting NF2 mutations

Meeting Abstract

Li, Y.; Chen, Y. B.; Zauderer, M.; Chang, J.; Offin, M.; Ladanyi, M.; Rekhtman, N.; Travis, W.; Yang, S. R.; Adusumilli, P.; more...
Modern Pathology (2021)

Fulltext@MSK | Save

Interpretation of methylthioadenosine phosphorylase (MTAP) expression by immunohistochemistry in malignant pleural mesothelioma is improved with monoclonal antibody 1813 compared to monoclonal antibody EPR6893

Meeting Abstract

Febres-Aldana, C.; Jungbluth, A.; Adusumilli, P.; Buonocore, D.; Chang, J.; Frosina, D.; Geronimo, J.; Hernandez, E.; Offin, M.; Rekhtman, N.; more...
Modern Pathology (2021)

Fulltext@MSK | Save